Insiders · Profile

Boor Kathryn Jean

Director at Sarepta Therapeutics. Filing since 11 Mar 2024. CIK 0001761826

Company
Date
Role
Action
Shares
Amount
Of holding
5 Dec 2024
Director
Sold at will
1,636
$205.40K
21.8%
11 Mar 2024
Director
Sold at will
761
$93.55K
9.2%
2 decisions on file.